SCHEMBL17343085

SCHEMBL17343085

[2H]C([2H])([2H])C([2H])([2H])N(C(=O)OCc1ccccc1)[C@@H](C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ SLC15A1 P46059 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ABCB1 P08183 1/20 0.39
▸ CTSK P43235 3/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ELANE P08246 1/20 0.38
▸ CTSB P07858 2/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CCR6 P51684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980750 0.83 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL7453248 0.83 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL15564386 0.83 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL25177942 0.81 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL7438640 0.81 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL7444517 0.80 ALDH1A1 (0.43) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL7411862 0.80 ALDH1A1 (0.45) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL9317837 0.80 ALDH1A1 (0.45) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL21492202 0.79 ALDH1A1 (0.47) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL21492669 0.79 ALDH1A1 (0.47) ALDH1A1L3MBTL1LMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394263-B2 Substituted hetero-azepinones F. HOFFMANN-LA ROCHE AG (CH) 2016-07-19 — — US disclosed
US-20150361059-A1 SUBSTITUTED HETERO-AZEPINONES HOFFMAN-LA ROCHE INC. (US) 2015-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361059-A1 SUBSTITUTED HETERO-AZEPINONES CCNY, CCNE1, CCND3 ALDH1A1 2459/4885L3MBTL1 1802/4885LMNA 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback